Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-08-13FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for a generic dexmethylphenidate hydrochloride product manufactured by Teva Pharmaceuticals USA,…
-
FDA approval · 2015-08-05FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved the original ANDA for dexmethylphenidate hydrochloride from Amneal Pharmaceuticals of New York LLC, a generic formulation for A…
-
EMA approval · 2015-07-24EMA recommends approval of treatment for attention deficit hyperactivity disorder
EMA recommends approval of a new treatment for attention deficit hyperactivity disorder, indicating positive assessment of its benefit-risk …
-
FDA approval · 2015-07-13FDA Approved: QUILLIVANT XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
The FDA approved a supplemental application for QUILLIVANT XR (methylphenidate hydrochloride) from NextWave Pharmaceuticals, Inc.
-
FDA approval · 2015-06-30FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for a generic dexmethylphenidate hydrochloride extended-release product by Par Health USA, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-06-15FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride CD from Lannett Company, Inc.
-
FDA approval · 2015-06-12FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for FOCALIN XR (dexmethylphenidate hydrochloride) from Sandoz Inc. This action represents a regulato…
-
FDA approval · 2015-06-09FDA Approved: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE — Original Application (KVK-Tech, Inc.)
The FDA approved KVK-Tech's methylphenidate hydrochloride extended-release as a generic drug through an Original ANDA.
-
FDA approval · 2015-06-02FDA Approved: METHYLPHENIDATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for methylphenidate from Sandoz Inc.
-
FDA approval · 2015-06-02FDA Approved: GUANFACINE EXTENDED-RELEASE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Guanfacine Extended-Release as an original ANDA for a generic extended-release guanfacine product from Upsher-Smith Laboratorie…
-
FDA approval · 2015-05-26FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Strattera (atomoxetine hydrochloride) from Eli Lilly and Company, indicating an updated appr…
-
FDA approval · 2015-04-17FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental NDA from Prasco Laboratories for a generic mixture of amphetamine salts: dextroamphetamine saccharate, amphetami…
-
FDA approval · 2015-04-17FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for FOCALIN XR (dexmethylphenidate hydrochloride) submitted by Sandoz Inc, indicating an approved re…
-
FDA approval · 2015-04-17FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
FDA approved a supplemental application for the Methylphenidate Transdermal System, a methylphenidate patch, submitted by Padagis US LLC.
-
FDA approval · 2015-04-17FDA Approved: METHYLIN — Supplemental Application (SHIONOGI INC.)
FDA approved a supplemental application for METHYLIN (methylphenidate hydrochloride) filed by Shionogi Inc.
-
FDA approval · 2015-04-17FDA Approved: DEXEDRINE SPANSULE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Dexedrine Spansule (dextroamphetamine sulfate) from Amneal Pharmaceuticals LLC.
-
FDA approval · 2015-04-17FDA Approved: FOCALIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for FOCALIN (dexmethylphenidate hydrochloride) submitted by Sandoz Inc.
-
FDA approval · 2015-04-17FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for CONCERTA (methylphenidate hydrochloride) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2015-04-17FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for dextroamphetamine sulfate submitted by SpecGx LLC.
-
FDA approval · 2015-04-17FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approves a supplemental application for Dextroamphetamine Sulfate from Prasco Laboratories.
-
FDA approval · 2015-04-17FDA Approved: QUILLIVANT XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
FDA approved a supplemental application for QUILLIVANT XR (methylphenidate hydrochloride) from NextWave Pharmaceuticals, Inc. This action co…
-
FDA approval · 2015-04-17FDA Approved: DEXTROAMPHETAMINE — Supplemental Application (Cranbury Pharmaceuticals, LLC)
The FDA approved a supplemental application for a dextroamphetamine product from Cranbury Pharmaceuticals, LLC.
-
FDA approval · 2015-04-17FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application from NorthStar RxLLC for a generic combination of four amphetamine salts (dextroamphetamine sacc…
-
FDA approval · 2015-04-17FDA Approved: APTENSIO XR — Original Application (Rhodes Pharmaceuticals L.P.)
The FDA approved Aptensio XR (methylphenidate hydrochloride) from Rhodes Pharmaceuticals as a new drug product for attention-deficit/hyperac…
-
FDA approval · 2015-04-17FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride CD submitted by Lannett Company, Inc., resulting in continued appr…